Doylestown Hospital is one of a limited number of medical centers nationwide that offer Blue Light Cystoscopy with Cysview®, a state-of-the art procedure that improves detection of certain bladder cancers.
Bladder Cancer Detection
Cystoscopy is the standard diagnostic tool for bladder cancer detection. Doctors who suspect patients may have bladder cancer use this procedure to look inside the bladder. A cystoscope lets the doctor inspect the bladder lining very closely for any abnormal growths or suspicious areas. Historically, cystoscopy was performed using only white light for visualizing suspicious lesions.
Blue Light Cystoscopy with Cysview®
Blue Light Cystoscopy (BLC™) with Cysview® is a technology that significantly improves the detection of non-muscle invasive bladder cancer compared to traditional White Light Cystoscopy alone.
Cysview is an optical imaging agent that is taken up by cancer cells in the bladder making them glow bright pink under blue light. Urologists are better able to see smaller tumors and flat lesions that may not be seen with white light. The urologist can immediately remove diseased tissue, ideally leaving a clean margin of healthy tissue around the resection site.
Blue Light Cystoscopy with Cysview represents an important advancement in diagnostic technology, enabling more accurate diagnosis of non-muscle invasive bladder cancer. Doylestown Hospital is pleased to be able to provide this advanced level of care to our patients.